Herpes-varicella-zoster.
D004986:Ether / Q000627:therapeutic use; D006561:Herpes Simplex / Q000276:immunology / Q000517:prevention & control / Q000628:therapy; D006566:Herpesviridae Infections / Q000628:therapy*; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000517:prevention & control / Q000628:therapy; D007372:Interferons / Q000627:therapeutic use; D009705:Nucleosides / Q000627:therapeutic use; D014740:Vidarabine / Q000627:therapeutic use
D009705:Nucleosides; D004986:Ether; D007372:Interferons; D014740:Vidarabine